跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
毕太维 - NMPA Drug Approval Details
Approvals
/
NMPA
/
毕太维
Approved
化学药品
毕太维
PIERRE FABRE MEDICAMENT
🇨🇳 National Medical Products Administration
Approval Date
Jun 30, 2025
Approval ID
8lIRf58033h
Company
PIERRE FABRE MEDICAMENT
Type
化学药品
Approval Details
Approval Id
8lIRf58033h
Approval Number
国药准字HJ20250082
Generic Name
恩考芬尼胶囊
Trade Name
毕太维
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
75mg
Reg Date
2025-06-30
Expired Date
2030-06-29
Company Name
PIERRE FABRE MEDICAMENT
Production Company Name
CATALENT PHARMA SOLUTIONS, LLC
Company Detail Path
/organization/pierre-fabre-medicament
Production Company Detail Path
/organization/catalent-pharma-solutions-llc-madison-wisconsin-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 30, 2025
Approval ID
8lIRf58033h
Type
化学药品
Back to NMPA Approvals